007足球比分即时网

Bio-Thera Solutions’ Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi) in the United States

2026-05-18

GUANGZHOU, China --- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline...

查看详情

01-032024

Bio-Thera Solutions Partners with Macter International to Market BAT1706, an Avastin®1 biosimilar, in Pakistan and Afghanistan

GUANGZHOU, China --- Bio-Thera Solutions (688177:SH), acommercial-stage biopharmaceutical company developing a pipeline ...
12-082023

FDA Approves Bio-Thera Solutions’ Avzivi® (bevacizumab-tnjn), a biosimilar referencing Avastin®

Avzivi® (BAT1706) is Bio-Thera Solution’second FDA approved product in the United StatesAvzivi® is the second biosimilar...
11-292023

Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara®

Theclinical comparative study met its primary endpoint and showed similar efficacyand comparable safety profile in patie...

上一页 ···13 14 15 16 17 ··· 下一页